FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Romina Carnevale

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Physiology

Anatomy

Procedures

Neoplasm Transplantation

Co-author Network

Publications

TOP 3
Martin Alfredo Rivas; Romina Carnevale; Cecilia J Proietti; Cinthia Rosemblit; Wendy Beguelin; Mariana Salatino; Eduardo H Charreau; Isabel Frahm; Sandra Sapia; Peter Brouckaert; Patricia V Elizalde; Roxana Schillaci
TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
Romina Carnevale; Cecilia J Proietti; Mariana Salatino; Alejandro J Urtreger; Guillermo Peluffo; Dean P Edwards; Viroj Boonyaratanakornkit; Eduardo H Charreau; Elisa Bal de Kier Joffé; Roxana Schillaci; Patricia V Elizalde
Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Mariana Salatino; W Beguelin; M G Peters; Romina Carnevale; Cecilia J Proietti; M D Galigniana; Cleber Giovane Vedoy; Roxana Schillaci; Eduardo H Charreau; Mari C Sogayar; Patricia V Elizalde
Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Romina Carnevale (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Martin Alfredo Rivas; Romina Carnevale; Cecilia J Proietti; Cinthia Rosemblit; Wendy Beguelin; Mariana Salatino; Eduardo H Charreau; Isabel Frahm; Sandra Sapia; Peter Brouckaert; Patricia V Elizalde; Roxana Schillaci
TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
Experimental cell research 2008;314(3):509-29.
2007: Romina Carnevale; Cecilia J Proietti; Mariana Salatino; Alejandro J Urtreger; Guillermo Peluffo; Dean P Edwards; Viroj Boonyaratanakornkit; Eduardo H Charreau; Elisa Bal de Kier Joffé; Roxana Schillaci; Patricia V Elizalde
Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Molecular endocrinology (Baltimore, Md.) 2007;21(6):1335-58.
2006: Mariana Salatino; W Beguelin; M G Peters; Romina Carnevale; Cecilia J Proietti; M D Galigniana; Cleber Giovane Vedoy; Roxana Schillaci; Eduardo H Charreau; Mari C Sogayar; Patricia V Elizalde
Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.
Oncogene 2006;25(59):7723-39.
2006: Roxana Schillaci; Mariana Salatino; Juliana Cassataro; Cecilia J Proietti; Guillermo H Giambartolomei; Martin Alfredo Rivas; Romina Carnevale; Eduardo H Charreau; Patricia V Elizalde
Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(6):3426-37.
2005: Cecilia J Proietti; Mariana Salatino; Cinthia Rosemblit; Romina Carnevale; Adali Pecci; Alberto R Kornblihtt; Alfredo A Molinolo; Isabel Frahm; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
Molecular and cellular biology 2005;25(12):4826-40.
2004: Mariana Salatino; Roxana Schillaci; Cecilia J Proietti; Romina Carnevale; Isabel Frahm; Alfredo A Molinolo; Adolfo Iribarren; Eduardo H Charreau; Patricia V Elizalde
Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Oncogene 2004;23(30):5161-74.
2004: Mariana Salatino; Roxana Schillaci; Cecilia J Proietti; Romina Carnevale; Eduardo H Charreau; Patricia V Elizalde
[Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer].
Medicina 2004;64(2):129-34.